Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2026-01-06 @ 5:00 PM
Study NCT ID:
NCT00468767
Status:
COMPLETED
Last Update Posted:
2008-04-02
First Post:
2007-05-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation
Sponsor:
Advanz Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-08
Start Date Type:
None
Primary Completion Date:
2004-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-11
Completion Date Type:
ACTUAL
First Submit Date:
2007-05-01
First Submit QC Date:
None
Study First Post Date:
2007-05-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-03-31
Last Update Post Date:
2008-04-02
Last Update Post Date Type:
ESTIMATED